Navigation Links
As a Result of Sustained Growth, ContinuLink Adds Industry Leader to Senior Management Team
Date:12/26/2013

Boca Raton, Florida (PRWEB) December 26, 2013

ContinuLink LLC, a leading provider of web based homecare agency management software, is proud to announce the addition of Jeremy Crow to their Senior Management team. “ContinuLink’s unprecedented growth in the Medicaid home and community based industry, including the recent addition of 39 Medicaid home health agency clients in 6 states, required us to add a proven industry leader to our support and implementation team. Jeremy has over 17 years of experience in the home health care technology space and has managed the implementation and customer support teams for another enterprise-level homecare software product,” says Scott Overhill, President of ContinuLink.

Jeremy will serve as the Director of Professional Services for ContinuLink and will be responsible for managing and leading the company’s implementation and support team members. “I am excited to be back in the post acute home health care space and especially with ContinuLink, where there is potential for significant growth,” stated Jeremy. ContinuLink President Scott Overhill welcomed Jeremy to the Senior Management team, stating, “We are excited to have Jeremy onboard. His knowledge and experience in implementation and support will be of great importance to our company as we continue to strengthen our customer acquisition and retention strategic approaches.”

As a further indication of ContinuLink’s long term support of the Medicaid home health industry, the company has been elected to the board of the National Council on Medicaid Home Care, an affiliate of the National Association for Home Care. “All of us here at NAHC are proud to work with ContinuLink,” said NAHC President Val J. Halamandaris. Bill Dombi, Executive Director of the Medicaid Council added, “ContinuLink is truly committed to supporting their rapidly growing user base of Medicaid home care providers and they understand the importance the Council brings to the industry.”

About ContinuLink
ContinuLink is the most sophisticated and scalable software solution for home health care agencies. ContinuLink continues its rapid growth with over 11,000 users at more than 519 agency locations, serving over 90,000 patients and managing over 33,000 caregivers in the Medicaid, Medicaid Waiver, Medicaid MCO, Private Pay, Supplemental Staffing, and Medicare lines of business. With its reliance on open Web technologies, ContinuLink leads the industry in technology based solutions for home care providers.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11445231.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Supreme Skin Introduces an Anti-Aging Microcurrent Facial in Asheville, NC that Restores the Skin, Similar to What Many Celebrities Now Choose for a Natural Result
2. The Results of PositiveSingles' Favorite Dreamlike Celebrity Weddings are In
3. Those Gut Feelings May be the Result of What You Eat
4. MedCenter TMJ Finds that Bed Buddy Provides Positive Results for Patients
5. UV Technologies, LLC, Makers of UV-Aid® Release Results of Study Showing Photo-Oxidation Technology Highly Effective in Preventing Colds, Flu, and Ear Infections
6. PositiveSingles Results of “Hottest Actor” Poll Are In
7. UTHealth program results in happier patients, lower costs in esophageal surgery
8. Vemurafenib: Result unchanged despite new data
9. Survey Results Indicate Healthcare Industry is Behind the Curve on ICD-10 Compliance Readiness
10. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New Statin Guidelines That Could Result in Millions of New Lipitor Prescriptions
11. Top Utah Facial Plastic Surgeon Finds Positive Results From Juvederm Voluma XC After Early Product Administration through Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: